Pancreatic Cancer Research

ResearcherFox Chase Cancer CenterNo recent work listed

Ariella M. Altman

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4191-0679; OpenAlex author ID A5070570838. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper

Papers 2

  1. The Addition of Chemoradiation to Adjuvant Chemotherapy is Associated With Improved Survival Following Upfront Surgical Resection for Pancreatic Cancer With No… Co-author DOI 10.1177/10732748221109991↗
  2. Completion of Adjuvant Chemotherapy After Upfront Surgical Resection for Pancreatic Cancer Is Uncommon Yet Associated With Improved Survival. Co-author DOI 10.1245/s10434-019-07602-6↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Eric Hans Jensen · 2 shared papers, 2019–2022 · strength 0.24
  2. Jason W. Denbo · 2 shared papers, 2019–2022 · strength 0.24
  3. Schelomo Marmor · 2 shared papers, 2019–2022 · strength 0.24
  4. Emil Lou · 2 shared papers, 2019–2022 · strength 0.24
  5. M J White · 1 shared paper, 2022 · strength 0.15
  6. Christopher James LaRocca · 1 shared paper, 2022 · strength 0.15
  7. Keith M. Wirth · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.